Exponent's Q3 Revenue Up, But Net Income and Cash Decline

TL;DR

**EXPO's revenue growth is masking a concerning drop in net income and cash, signaling potential trouble ahead despite shareholder returns.**

AI Summary

Exponent Inc. (EXPO) reported mixed financial results for the nine months ended October 3, 2025. Revenues increased to $434.589 million, up 3.04% from $421.748 million in the prior year period. However, net income decreased by 4.88% to $81.247 million, compared to $85.413 million for the nine months ended September 27, 2024. Basic net income per share also saw a slight decline to $1.59 from $1.67. Operating income decreased to $90.647 million from $92.304 million, a 1.8% drop. The company's cash and cash equivalents significantly decreased by 19.9% from $258.901 million at January 3, 2025, to $207.380 million at October 3, 2025, primarily due to substantial share repurchases totaling $72.712 million and dividend payments of $46.652 million. Accounts receivable increased by $20.589 million, indicating potential cash flow challenges from collections. The company continues to rely heavily on time and materials contracts, which constituted 79% of total revenues for the nine months ended October 3, 2025.

Why It Matters

Exponent's mixed results signal a potential slowdown in profitability despite revenue growth, which could concern investors looking for consistent earnings. The significant reduction in cash and cash equivalents, driven by share repurchases and dividends, suggests a capital allocation strategy that might be unsustainable if net income continues to decline. This could impact the company's ability to fund future growth initiatives or maintain dividend payouts, potentially affecting employee morale and customer project capacity. In a competitive consulting market, a weakening financial position could make EXPO less attractive compared to rivals with stronger balance sheets and clearer growth trajectories.

Risk Assessment

Risk Level: medium — The company's net income decreased by 4.88% to $81.247 million for the nine months ended October 3, 2025, compared to $85.413 million in the prior year. Additionally, cash and cash equivalents declined significantly by $51.521 million, from $258.901 million to $207.380 million, primarily due to $72.712 million in share repurchases and $46.652 million in dividends, which outpaced cash generated from operations.

Analyst Insight

Investors should closely monitor Exponent's upcoming earnings calls for management's explanation of the net income decline and cash burn. Consider reducing exposure if profitability trends do not reverse, as the current capital allocation strategy appears to be eroding the cash position without a corresponding increase in net income.

Financial Highlights

debt To Equity

N/A

revenue

$434.589M

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

$81.247M

eps

$1.59

gross Margin

N/A

cash Position

$207.380M

revenue Growth

+3.04%

Revenue Breakdown

Key Numbers

• $434.589M — Revenues (Increased by 3.04% for the nine months ended October 3, 2025, from $421.748M in the prior year.)
• $81.247M — Net Income (Decreased by 4.88% for the nine months ended October 3, 2025, from $85.413M in the prior year.)
• $207.380M — Cash and Cash Equivalents (Decreased by 19.9% from $258.901M at January 3, 2025, to October 3, 2025.)
• $72.712M — Common Stock Repurchases (Significant cash outflow for the nine months ended October 3, 2025.)
• $46.652M — Dividends Paid (Significant cash outflow for the nine months ended October 3, 2025.)
• $1.59 — Basic Net Income Per Share (Decreased from $1.67 in the prior year period.)
• 79% — Time and Materials Revenues (Represents the majority of revenue for the nine months ended October 3, 2025.)
• $22.686M — Increase in Accounts Receivable (Negative impact on cash flow from operating activities for the nine months ended October 3, 2025.)

Key Players & Entities

• EXPONENT INC (company) — registrant
• U.S. Securities and Exchange Commission (regulator) — filing oversight
• $434.589 million (dollar_amount) — total revenues for nine months ended October 3, 2025
• $81.247 million (dollar_amount) — net income for nine months ended October 3, 2025
• $207.380 million (dollar_amount) — cash and cash equivalents at October 3, 2025
• $72.712 million (dollar_amount) — repurchase of common stock for nine months ended October 3, 2025
• $46.652 million (dollar_amount) — dividends and dividend equivalents rights for nine months ended October 3, 2025
• Nasdaq Global Select Market (company) — exchange where EXPO common stock is registered
• FASB (regulator) — Financial Accounting Standards Board
• ASU 2023-09 (regulator) — Income Taxes (Topic 740): Improvements to Income Tax Disclosures

FAQ

Risk Factors

• Share Repurchases and Dividends Impacting Cash [medium — financial]: The company's cash and cash equivalents decreased by 19.9% from $258.901 million to $207.380 million due to substantial share repurchases ($72.712 million) and dividend payments ($46.652 million) during the nine months ended October 3, 2025. This significant outflow reduces liquidity and financial flexibility.
• Increasing Accounts Receivable [medium — financial]: Accounts receivable increased by $20.589 million for the nine months ended October 3, 2025. This rise suggests potential challenges in collecting payments from clients, which could negatively impact operating cash flow.
• Reliance on Time and Materials Contracts [medium — operational]: The company's heavy reliance on time and materials contracts (79% of revenue) exposes it to fluctuations in labor costs and project scope changes. While this model offers flexibility, it can also lead to margin pressures if not managed effectively.
• Declining Net Income and EPS [medium — financial]: Net income decreased by 4.88% to $81.247 million and basic EPS fell to $1.59 for the nine months ended October 3, 2025. This trend, despite revenue growth, indicates potential margin compression or increased operating expenses.
• Compliance with Financial Reporting Standards [low — regulatory]: As a publicly traded company, Exponent Inc. must adhere to stringent SEC regulations and accounting standards. Non-compliance can lead to fines, legal action, and reputational damage.

Industry Context

Exponent Inc. operates in the scientific and engineering consulting services industry. This sector is characterized by a demand for specialized expertise across various disciplines, including engineering, materials science, and environmental consulting. Key trends include the increasing complexity of product development, stringent regulatory environments, and the need for independent expert analysis in litigation and insurance claims. Competition comes from a range of firms, from large, diversified engineering consultancies to smaller, niche specialists.

Regulatory Implications

As a publicly traded entity, Exponent Inc. is subject to the oversight of the Securities and Exchange Commission (SEC), requiring adherence to rigorous financial reporting standards (GAAP) and disclosure requirements. Any misstatements or non-compliance can lead to investigations, penalties, and reputational damage. Furthermore, the nature of its consulting services may involve compliance with industry-specific regulations depending on the client sectors served.

What Investors Should Do

1. Monitor accounts receivable trends closely.
2. Analyze the drivers of net income decline despite revenue growth.
3. Evaluate the impact of capital allocation decisions on liquidity.
4. Assess the sustainability of the Time and Materials revenue model.

Key Dates

• 2025-10-03: End of Nine Months Reporting Period — Key financial results for the period, including revenue, net income, and cash position, are reported.
• 2025-01-03: Beginning of Nine Months Reporting Period (Balance Sheet Date) — Represents the starting cash and cash equivalents balance against which changes are measured.
• 2024-09-27: End of Prior Year Nine Months Reporting Period — Provides the comparative financial data for revenue, net income, and EPS.

Glossary

Time and Materials Contracts

A type of contract where the client pays for the actual labor hours spent on a project and the cost of materials used. (This contract type constitutes the majority (79%) of Exponent Inc.'s revenue, directly impacting its revenue recognition and cost management strategies.)

Share Repurchases

The company's act of buying back its own shares from the open market, reducing the number of outstanding shares. (Significant share repurchases totaling $72.712 million contributed to a decrease in cash and cash equivalents, impacting liquidity.)

Basic Net Income Per Share

The portion of a company's profit allocated to each outstanding share of common stock, calculated by dividing net income by the weighted-average number of shares outstanding. (A decline in basic EPS from $1.67 to $1.59 indicates a decrease in profitability on a per-share basis, despite revenue growth.)

Accounts Receivable

Money owed to a company by its customers for goods or services delivered but not yet paid for. (An increase of $20.589 million in accounts receivable suggests potential cash flow challenges related to client collections.)

Year-Over-Year Comparison

For the nine months ended October 3, 2025, Exponent Inc. saw a modest 3.04% increase in revenue to $434.589 million compared to the prior year. However, this top-line growth was not mirrored in profitability, as net income declined by 4.88% to $81.247 million, and basic EPS fell to $1.59 from $1.67. The company's cash position also weakened significantly, decreasing by 19.9% due to substantial capital returns to shareholders, while accounts receivable saw an increase, indicating potential collection headwinds.

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share EXPO Nasdaq Global Select

Filing Documents

• expo-20251003.htm (10-Q) — 2488KB
• expo-ex31_1.htm (EX-31.1) — 13KB
• expo-ex31_2.htm (EX-31.2) — 13KB
• expo-ex32_1.htm (EX-32.1) — 7KB
• expo-ex32_2.htm (EX-32.2) — 7KB
• 0001193125-25-272273.txt ( ) — 8178KB
• expo-20251003.xsd (EX-101.SCH) — 752KB
• expo-20251003_htm.xml (XML) — 1686KB

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION 3 Item 1.

Financial Statements (unaudited)

Financial Statements (unaudited): 3 Condensed Consolidated Balance Sheets October 3, 2025 and January 3, 2025 3 Condensed Consolidated Statements of Income For the Three and Nine Months Ended October 3, 2025 and September 27, 2024 4 Condensed Consolidated Statements of Comprehensive Income For the Three and Nine Months Ended October 3, 2025 and September 27, 2024 5 Condensed Consolidated Statements of Stockholders' Equity For the Three and Nine Months Ended October 3, 2025 and September 27, 2024 6 Condensed Consolidated Statements of Cash Flows For the Nine Months Ended October 3, 2025 and September 27, 2024 8 Notes to Unaudited Condensed Consolidated Financial Statements 9 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 21 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 30 Item 4.

Controls and Procedures

Controls and Procedures 30

– OTHER INFORMATION

PART II – OTHER INFORMATION 31 Item 1.

Legal Proceedings

Legal Proceedings 31 Item 1A.

Risk Factors

Risk Factors 31 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 31 Item 3. Defaults Upon Senior Securities 31 Item 4. Mine Safety Disclosures 31 Item 5. Other Information 31 Item 6. Exhibits 32

Signatures

Signatures 33 - 2 -

– FINANC IAL INFORMATION

PART I – FINANC IAL INFORMATION

Financ ial Statements

Item 1. Financ ial Statements EXPONENT, INC. Condensed Consolida ted Balance Sheets October 3, 2025 and January 3, 2025 (unaudited) (In thousands, except par value) October 3, 2025 January 3, 2025 Assets Current assets: Cash and cash equivalents $ 207,380 $ 258,901 Accounts receivable, net of allowance for contract losses and doubtful accounts of $ 7,625 and $ 6,141 at October 3, 2025 and January 3, 2025, respectively 181,996 161,407 Prepaid expenses and other current assets 27,410 26,573 Total current assets 416,786 446,881 Property, equipment and leasehold improvements, net of accumulated depreciation and amortization of $ 119,644 and $ 112,202 at October 3, 2025 and January 3, 2025, respectively 72,244 73,007 Operating lease right-of-use assets 73,312 75,248 Goodwill 8,607 8,607 Deferred income taxes 63,088 57,127 Deferred compensation plan assets 121,437 110,259 Other assets 5,975 6,141 Total assets $ 761,449 $ 777,270 Liabilities and Stockholders' Equity Current liabilities: Accounts payable and accrued liabilities $ 26,453 $ 22,136 Accrued payroll and employee benefits 108,922 119,285 Deferred revenues 12,902 16,369 Operating lease liabilities 6,490 5,393 Total current liabilities 154,767 163,183 Other liabilities 4,589 4,289 Deferred compensation plan liabilities 123,124 112,646 Operating lease liabilities 76,108 76,084 Total liabilities 358,588 356,202 Stockholders' equity: Common stock, $ 0.001 par value; 120,000 shares authorized; 65,707 shares issued at October 3, 2025 and January 3, 2025 66 66 Additional paid-in capital 367,010 345,689 Accumulated other comprehensive loss Foreign currency translation adjustments ( 2,402 ) ( 3,791 ) Retained earnings 658,788 624,151 Treasury stock, at cost; 15,757 and 14,893 shares held at October 3, 2025 and January 3, 2025, respecti

View Full Filing

View this 10-Q filing on SEC EDGAR